These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8076589)

  • 1. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers.
    Glass CK
    Endocr Rev; 1994 Jun; 15(3):391-407. PubMed ID: 8076589
    [No Abstract]   [Full Text] [Related]  

  • 2. Transition from monomeric to homodimeric DNA binding by nuclear receptors: identification of RevErbAalpha determinants required for RORalpha homodimer complex formation.
    Moraitis AN; Giguère V
    Mol Endocrinol; 1999 Mar; 13(3):431-9. PubMed ID: 10077000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
    Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
    J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features involved in the formation of a complex between the monomeric or the dimeric form of the rev-erb beta DNA-binding domain and its DNA reactive sites.
    Terenzi H; Alzari PM; Zakin MM
    Biochemistry; 1998 Aug; 37(33):11488-95. PubMed ID: 9708984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor.
    Freedman LP; Arce V; Perez Fernandez R
    Mol Endocrinol; 1994 Mar; 8(3):265-73. PubMed ID: 8015545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factors 3: nuclear receptors.
    Gronemeyer H; Laudet V
    Protein Profile; 1995; 2(11):1173-308. PubMed ID: 8681033
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors.
    Forman BM; Chen J; Blumberg B; Kliewer SA; Henshaw R; Ong ES; Evans RM
    Mol Endocrinol; 1994 Sep; 8(9):1253-61. PubMed ID: 7838158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-dependent folding and stability of nuclear hormone receptor DNA-binding domains.
    Low LY; Hernández H; Robinson CV; O'Brien R; Grossmann JG; Ladbury JE; Luisi B
    J Mol Biol; 2002 May; 319(1):87-106. PubMed ID: 12051939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterodimerization and deoxyribonucleic acid-binding properties of a retinoid X receptor-related factor.
    Ribeiro RC; Apriletti JW; Yen PM; Chin WW; Baxter JD
    Endocrinology; 1994 Nov; 135(5):2076-85. PubMed ID: 7956930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B.
    Meinke G; Sigler PB
    Nat Struct Biol; 1999 May; 6(5):471-7. PubMed ID: 10331876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of RXR-DNA interactions.
    Zhao Q; Chasse SA; Devarakonda S; Sierk ML; Ahvazi B; Rastinejad F
    J Mol Biol; 2000 Feb; 296(2):509-20. PubMed ID: 10669605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of dominant negative activity by nuclear hormone receptors.
    Yen PM; Chin WW
    Mol Endocrinol; 1994 Nov; 8(11):1450-4. PubMed ID: 7877614
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative splicing determines the interaction of SMRT isoforms with nuclear receptor-DNA complexes.
    Faist F; Short S; Kneale GG; Sharpe CR
    Biosci Rep; 2009 Jun; 29(3):143-9. PubMed ID: 18752469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
    Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
    Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific DNA recognition by peptide heterodimers.
    Sawada M; Aizawa Y; Ueno M; Morii T; Sugiura Y
    Nucleic Acids Symp Ser; 1995; (34):141-2. PubMed ID: 8841592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the repertoire of nuclear receptor binding sites in genomes.
    Cotnoir-White D; Laperrière D; Mader S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical approaches untangling sequence-specific DNA binding by proteins.
    Sato S; Hagihara M; Sugimoto K; Morii T
    Chemistry; 2002 Nov; 8(22):5066-71. PubMed ID: 12412056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective recognition of tandemly repeated DNA sequences by homo- and heterodimers of short peptides.
    Aizawa Y; Morii T; Sugiura Y
    Nucleic Acids Symp Ser; 1997; (37):311-12. PubMed ID: 9586124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.